Skip to main content

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 33))

  • 79 Accesses

Abstract

The traditional belief of surgeons that allogeneic blood is an effective and safe therapy with minimal risks has been challenged by a heightened awareness of the problems of transfusion reactions, disease transmission and immunomodulation related to red blood cell transfusion. Surgeons have responded to these challenges by reassessing the reasons for transfusion, increasing the use of autologous blood, modifying surgical techniques to reduce blood loss, and employing various drugs to reduce transfusion need. Current practice policies recommend that elective transfusion of allogeneic blood should be viewed as an outcome to be avoided in surgical patients [1]. Each time we reach this goal, our patients’ safety and outcomes will be improved. Of primary importance is the need for the surgeon to change from a casual approach to allogeneic blood transfusion to one characterised by thoughtful planning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spence RK for the Blood Management Practice Guidelines Conference, Surgical Red Blood Cell Transfusion Practice Policies, Am J Surg 1995;170:6A(Suppl):3S–12S.

    Article  PubMed  CAS  Google Scholar 

  2. Van Wyck DB. Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 1989; 14(2 Suppl 1):9–13.

    PubMed  Google Scholar 

  3. Tasaki T, Ohto H, Noguchi M, et al. Iron and erythropoietin measurement in autologous blood donors with anemia: implications for management. Transfusion 1994;34: 337–343.

    Article  PubMed  CAS  Google Scholar 

  4. Ashby EC. Total dose iron-dextran infusions in general surgery. Lancet 1967;2:807–809.

    Article  PubMed  CAS  Google Scholar 

  5. Nissenson AR. Erythropoietin treatment in peritoneal dialysis patients. Perit Dial Int 1994;14(Suppl 3):S63–S69.

    PubMed  Google Scholar 

  6. Spivak JL. Recombinant human erythropoietin and the anemia of cancer [editorial]. Blood 1994;84:997–1004.

    PubMed  CAS  Google Scholar 

  7. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994;34:66–71.

    Article  PubMed  CAS  Google Scholar 

  8. Beris P, Mermillod B, Levy G, et al. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study. Vox Sang 1993;65: 212–218.

    Article  PubMed  CAS  Google Scholar 

  9. Atabek U, Alvarez R, Pello MJ, et al. Erythropoietin Accelerates Heamtocrit Recovery in Post-Surgical Anemia. Amer Surg 1994;61:74–77.

    Google Scholar 

  10. Popovsky MA. Quality of blood components filtered before storage and at the beside: implications for transfusion practice. Transfusion 1996;36:470–474.

    Article  PubMed  CAS  Google Scholar 

  11. Higgins VL. Leukocyte-reduced blood components: patient benefits and practical applications. Oncol Nurs Forum 1996;23:659–667.

    PubMed  CAS  Google Scholar 

  12. Bradley J. The blood transfusion effect: experimental aspects. Immunology Letters. 1991;29:127–132.

    Article  PubMed  CAS  Google Scholar 

  13. Klein HG. Immunologic aspects of blood transfusion. Semin Oncol 1994;21 (Suppl 3): 16–20.

    PubMed  CAS  Google Scholar 

  14. Triulzi D, Blumberg N, Heal J. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci 1990;28:95–107.

    Article  PubMed  CAS  Google Scholar 

  15. Blumberg N, Heal J. Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med 1990;63: 429–433.

    PubMed  CAS  Google Scholar 

  16. Practice strategies for elective red blood cell transfusion. Ann Int Med 1992; 116: 403–406.

    Google Scholar 

  17. Perioperative red cell transfusion. NIH Consensus Development Conference Statement. Bethesda, MD: NIH, 1988:1–17.

    Google Scholar 

  18. Gerson Greenberg A. A physiologic basis for red blood cell transfusion decisions. Am J Surg 1995;170(6A Suppl):44S–48S.

    Article  Google Scholar 

  19. Carson, JL. Morbidity risk assessment in the surgically anemic patient. Am J Surg 1995;170:6A (Suppl):32S–36S.

    Article  PubMed  CAS  Google Scholar 

  20. Goodnough LT, Grishaber JE, Birkmeyer JD, et al. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 1994;44:226–231.

    Article  PubMed  CAS  Google Scholar 

  21. Sculco TP. Blood management in orthopedic surgery. Am J Surg 1995;170:(6A Suppl):60S–63S

    Article  PubMed  CAS  Google Scholar 

  22. Goodnough LT, Vizmeg A, Robeeks R, et al. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation program. Vox Sang 1992;63:90–95.

    Article  PubMed  CAS  Google Scholar 

  23. Goodnough LT, Brittenham G. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990;115:28–35

    PubMed  CAS  Google Scholar 

  24. Goodnough LT, Rudick S, Price TH, et al. Increased collection of autologous blood preoperatively with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163–1167.

    Article  PubMed  CAS  Google Scholar 

  25. Beris P, Mermillod B, Levy G, et al. Recombinant human erythropoietin as an adjuvant treatment for autologous blood donation. Vox Sang 1993;65:2124–2138.

    Article  Google Scholar 

  26. Biesma DH, Marx JJ, Kraaijenhagen RJ, et al. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367–370.

    Article  PubMed  CAS  Google Scholar 

  27. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increasae the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55–59.

    Article  PubMed  CAS  Google Scholar 

  28. Price TH, Goodnough LT, Vogler WR, et al. Improving the efficacy of autologous blood donation with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropaietin. Am J Med 1996;101(Suppl 2A):22S–27S.

    Article  PubMed  CAS  Google Scholar 

  29. Healy JC, Frankfurter SA, Graves BK, Reddy RL, Beck JR. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis. Arch Pathol Lab Med 1994; 118:465–470.

    PubMed  CAS  Google Scholar 

  30. Britton L, Eastlund D, Dziuban S, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989;47:529–532.

    Article  PubMed  CAS  Google Scholar 

  31. Spiess BD. Pro: autologous blood should be available for elective cardiac surgery. J Cardiothorac Vasc Anesth 1994;84:231–237

    Article  Google Scholar 

  32. D’Ambra MN, Kaplan DK. Alternatives to allogeneic blood use in surgery: acute normovolemic hemodilution and preoperative autologous donation. Am J Surg 1995; 170:6A(Suppl):49S–52S.

    Article  PubMed  Google Scholar 

  33. Monk TG, Goodnough LT, Birkmeyer JD, et al. Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous donation in patients undergoing radical retropubic prostatectomy. Transfusion 1995;35:559–565.

    Article  PubMed  CAS  Google Scholar 

  34. Monk TG, Goodnough LT, Andriole GL, et al. Preoperative recombinant human erythropoietin therapy enhances ther efficacy of acute normovolemic hemodilution. Anesth Analg 1995;80:S230.

    Google Scholar 

  35. Stehling L, Zauder HL. Acute normovolemic hemodilution. Transfusion 1991;31: 857–868.

    Article  PubMed  CAS  Google Scholar 

  36. Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion 1991;31:662–675.

    Article  PubMed  CAS  Google Scholar 

  37. Giordano GF, Giordano DM, Wallace BA, et al: An analysis of 9918 consecutive perioperative autotransfusions. Surg Gyn Obst 1993; 176:103–110.

    PubMed  CAS  Google Scholar 

  38. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298–304.

    Article  PubMed  CAS  Google Scholar 

  39. Baer HU, Stain SC, Guastella T, Maddern GJ, Blumgart LH. Hepatic resection using a water jet dissector. HPB Surg 1993;60:189–196; discussion 196-8.

    Article  Google Scholar 

  40. Wu CC, Yang MD, Liu TJ. Improvements in hepatocellular carcinoma resection by intraoperative ultrasonography and intermittent hepatic inflow blood occlusion. Jpn J Clin Oncol 1992;22:107–112.

    PubMed  CAS  Google Scholar 

  41. Zhou XD, Tang ZY, Yu YQ, et al. Microwave surgery in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993;9:318–322.

    Article  PubMed  CAS  Google Scholar 

  42. Green MR, Christensen KP. Arthroscopic versus open Bankart procedures: a comparison of early morbidity and complications. Arthroscopy 1993;9:371–374.

    Article  PubMed  CAS  Google Scholar 

  43. Raut VV, Stone MH, Wroblewski BM. Reduction of postoperative blood loss after press-fit condylar knee arthroplasty with use of a femoral intramedullary plug. J Bone Joint Surg Am 1993;75:1356–1357.

    PubMed  CAS  Google Scholar 

  44. Levy AS, Marmar E. The role of cold compression dressings in the postoperative treatment of total knee arthroplasty. Clin Orthop 1993;297:174–178.

    PubMed  Google Scholar 

  45. McCormick PA, Dick R, Burroughs AK. Review article: the transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension. Aliment Pharmacol Ther 1994;80:273–282.

    Google Scholar 

  46. Orloff MJ, Bell RH Jr., Orloff MS, Hardison WG, Greenburg AG. Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in un-selected cirrhotic patients with bleeding varices [see comments]. Hepatology 1994; 20:863–872.

    Article  PubMed  CAS  Google Scholar 

  47. Parodi JC, Criado FJ, Barone HD, Schonholz C, Queral LA. Endoluminal aortic aneurysm repair using a balloon-expandable stent-graft device: a progress report. Ann Vasc Surg 1994;8:523–529.

    Article  PubMed  CAS  Google Scholar 

  48. Yusuf S, Baker D, Chuter T, Whitaker S, Wenham P, Hopkinson B. Transfemoral endoluminal repair of abdominal aortic aneurysm with bifurcated graft. Lancet 1994;344:650–651.

    Article  PubMed  CAS  Google Scholar 

  49. Senagore AJ, Luchtefeld MA, Mackeigan JM, Mazier WP. Open colectomy versus laparoscopic colectomy: are there differences? Am Surg 1993;59:549–553; discussion 553-54.

    PubMed  CAS  Google Scholar 

  50. Go H, Takeda M, Takahashi H, et al. Laparoscopic adrenalectomy for primary aldo-steronism: a new operative method. J Laparoendosc Surg 1993;30:455–459.

    Article  Google Scholar 

  51. Suzuki K, Kageyama S, Ueda D, et al. Laparoscopic adrenalectomy: clinical experience with 12 cases [see comments]. J Urol 1993; 150:1099–1102.

    PubMed  CAS  Google Scholar 

  52. Vietz PF, Ahn TS. A new approach to hysterectomy without colpotomy: pelviscopic intrafascial hysterectomy. Am J Obstet Gynecol 1994; 170:609–613.

    PubMed  CAS  Google Scholar 

  53. Arbogast JD, Welch RA, Riza ED, Ricaurte EL, Pieper DR. Laparoscopically assisted vaginal hysterectomy appears to be an alternative to total abdominal hysterectomy. J Laparoendosc Surg 1994;4:185–190.

    Article  PubMed  CAS  Google Scholar 

  54. Tan AK, Rothstein J, Tewfik TL. Ambulatory tonsillectomy and adenoidectomy: complications and associated factors. J Otolaryngol 1993;22:442–446.

    PubMed  CAS  Google Scholar 

  55. Wyman A, Rogers K. Randomized trial of laser scalpel for modified radical mastectomy [see commentsj. Br J Surg 1993;80:871–873.

    Article  PubMed  CAS  Google Scholar 

  56. Tchabo JG, Thomure MF, Tomai IP. A comparison of laser and cold knife coniza-tion. Int Surg 1993;78:131–132.

    PubMed  CAS  Google Scholar 

  57. Bhatta N, Isaacson K, Flotte T, Schiff I, Anderson RR. Injury and adhesion formation following ovarian wedge resection with different thermal surgical modalities. Lasers Surg Med 1993;13A:344–352.

    Article  Google Scholar 

  58. Blackwell KE, Ross DA, Kapur P, Calcaterra TC. Propofol for maintenance of general anesthesia: a technique to limit blood loss during endoscopic sinus surgery. Am J Otolaryngol 1993; 14:262–266.

    Article  PubMed  CAS  Google Scholar 

  59. Kram H, Nathan R, Stafford F, et al. Fibrin glue achieves hemostasis in patients with coagulation disorders. Arch Surg 1989; 124:384–388.

    Article  Google Scholar 

  60. Fremes S, Wong B, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994;58:1580–1588.

    Article  PubMed  CAS  Google Scholar 

  61. Rupp RE, Ebraheim NA, Saddemi SR, et al. Management of a multiply injured Jehovah’s Witness with severe acute anemia. Orthop Rev 1993;22:847–850.

    PubMed  CAS  Google Scholar 

  62. Ford PA, Henry DH. Using r-HuEPO in patients unwilling to accept blood transfusions. Erythropoiesis. 1996;7:63–66.

    Google Scholar 

  63. Ravikumar TS, Mani S, Zamek R, et al. Preoperative erythropoietin (Procrit) in abdominal cancer surgery [abstract no. 74]. In: Perry MC (ed). Proceedings of the 32 nd Annual Meeting of the American Society of Clinical Oncology, 1996 May 18-21; Philadelphia. Toronto: WB Saunders, 1996:276.

    Google Scholar 

  64. Canadian orthopedic perioperative erythropoietin study group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;34:1227–1232.

    Google Scholar 

  65. Paris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med Suppl 1996; 101:28–32.

    Google Scholar 

  66. D’AmbraZ MN, Lunch KE, Bocaggno J, et al. Effect of perioperative administration of recombinant human erythropoietin in CABG patients. Anesthesiology (Abstract) 1992;77:A159.

    Article  Google Scholar 

  67. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Amer J Surg. 1995;170(Suppl):37S–43S.

    Article  PubMed  CAS  Google Scholar 

  68. Breymann C, Bauer C, Major A, et al. Optimal timing of repeat rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. Brit J Haematol 1996;92:295–301.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Spence, R.K. (1998). The Management of Anaemia in the Surgical Patient: What’s New?. In: Sibinga, C.T.S., Das, P.C., Fratantoni, J.C. (eds) Alternative Approaches to Human Blood Resources in Clinical Practice. Developments in Hematology and Immunology, vol 33. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5619-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5619-0_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7571-5

  • Online ISBN: 978-1-4615-5619-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics